Difference between revisions of "Part:BBa K5133007"
Line 3: | Line 3: | ||
<partinfo>BBa_K5133007 short</partinfo> | <partinfo>BBa_K5133007 short</partinfo> | ||
− | + | ||
+ | Group: <b>GEC-China (iGEM 2024, team number: #5133)</b> | ||
+ | |||
+ | |||
+ | ==<b>Brief introduction</b>== | ||
+ | |||
+ | This basic part is derived from plasmid pFB398<sup>[1]</sup>, including a DNA sequence for coding Microcin M, an antimicrobial peptide produced by probiotic <i>E. coli</i> Nissle 1917. By assembling with T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS (<bbpart>BBa_K5133001</bbpart>), and T7 terminator (<bbpart>BBa_K5133003</bbpart>) derived from plasmid pJL1<sup>[2]</sup>, this part is used for the construction of composite part <bbpart>BBa_K5133008</bbpart> to demonstrate the <i>in vitro</i> production of antimicrobial peptides by CFPS. | ||
+ | |||
+ | |||
+ | ==<b>Design and characterization</b>== | ||
+ | |||
+ | The plasmid design of this biological part is shown as <b>Figure 1</b>, assembled with iGEM standard backbone <bbpart>pSB1C3</bbpart>. To validate the correctness of DNA sequence, result of Sanger sequencing for <bbpart>BBa_K5133008</bbpart> show the successful assembly among T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS (<bbpart>BBa_K5133001</bbpart>), Microcin M (this part), and T7 terminator (<bbpart>BBa_K5133003</bbpart>) in <b>Figure 2</b>. | ||
+ | |||
+ | |||
+ | <center> | ||
+ | <html lang="en"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <title>Resizable Image</title> | ||
+ | <style> | ||
+ | .resizable-img1 { | ||
+ | max-width: 60%; | ||
+ | height: auto; | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | <img src="https://static.igem.wiki/teams/5133/bba-k5133007-1.jpg" class="resizable-img1"> | ||
+ | </body> | ||
+ | </html> | ||
+ | </center> | ||
+ | |||
+ | |||
+ | <center><b>Figure 1. Schematic design of this part, generated by SnapGene.</b></center> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <center> | ||
+ | <html lang="en"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <title>Resizable Image</title> | ||
+ | <style> | ||
+ | .resizable-img2 { | ||
+ | max-width: 90%; | ||
+ | height: auto; | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | <img src="https://static.igem.wiki/teams/5133/bba-k5133007-2.jpg" class="resizable-img2"> | ||
+ | </body> | ||
+ | </html> | ||
+ | </center> | ||
+ | |||
+ | |||
+ | <center><b>Figure 2. Validation of DNA sequence by Sanger sequencing, generated by SnapGene.</b></center> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ==<b>Usages</b>== | ||
+ | |||
+ | This part is used for the construction of composite part <bbpart>BBa_K5133008</bbpart> (Microcin M generator) to demonstrate the feasibility of <i>in vitro</i> antimicrobial peptide production by CFPS. | ||
+ | |||
+ | |||
+ | |||
+ | ==<b>DNA sequence (from 5' to 3')</b>== | ||
+ | |||
+ | atgagaaaactatctgaaaatgaaataaaacaaatatctggaggtgacgggaatgacgggcaggcagaattaattgctattggttcacttgctggtacgtttattagcccgggatttggttctattgcaggggcttat | ||
+ | ataggtgataaagtacattcatgggcaacgactgcgacggttagtccctccatgtctccctcaggtataggattatcatcccagtttggatccggcagaggtacatcaagtgcctcttcgtctgcggggagtggaagt<font color="red">catcatcatcatcatcac</font>taa | ||
+ | |||
+ | <font color="red">Red font: 6×His-Tag, for detecting the <i>in vitro</i> production of Microcin M by Western-Blot analysis</font> | ||
+ | |||
+ | |||
+ | |||
+ | ==<b>References</b>== | ||
+ | |||
+ | [1] Ba, F. et al. Expanding the toolbox of probiotic <i>Escherichia coli</i> Nissle 1917 for synthetic biology. <b>Biotechnology Journal</b> 19, 2300327 (2024). doi: 10.1002/biot.202300327 | ||
+ | |||
+ | [2] https://www.addgene.org/69496/ | ||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 08:42, 27 July 2024
Microcin M
Group: GEC-China (iGEM 2024, team number: #5133)
Brief introduction
This basic part is derived from plasmid pFB398[1], including a DNA sequence for coding Microcin M, an antimicrobial peptide produced by probiotic E. coli Nissle 1917. By assembling with T7 promoter (BBa_K5133000), RBS (BBa_K5133001), and T7 terminator (BBa_K5133003) derived from plasmid pJL1[2], this part is used for the construction of composite part BBa_K5133008 to demonstrate the in vitro production of antimicrobial peptides by CFPS.
Design and characterization
The plasmid design of this biological part is shown as Figure 1, assembled with iGEM standard backbone pSB1C3. To validate the correctness of DNA sequence, result of Sanger sequencing for BBa_K5133008 show the successful assembly among T7 promoter (BBa_K5133000), RBS (BBa_K5133001), Microcin M (this part), and T7 terminator (BBa_K5133003) in Figure 2.
Usages
This part is used for the construction of composite part BBa_K5133008 (Microcin M generator) to demonstrate the feasibility of in vitro antimicrobial peptide production by CFPS.
DNA sequence (from 5' to 3')
atgagaaaactatctgaaaatgaaataaaacaaatatctggaggtgacgggaatgacgggcaggcagaattaattgctattggttcacttgctggtacgtttattagcccgggatttggttctattgcaggggcttat ataggtgataaagtacattcatgggcaacgactgcgacggttagtccctccatgtctccctcaggtataggattatcatcccagtttggatccggcagaggtacatcaagtgcctcttcgtctgcggggagtggaagtcatcatcatcatcatcactaa
Red font: 6×His-Tag, for detecting the in vitro production of Microcin M by Western-Blot analysis
References
[1] Ba, F. et al. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology. Biotechnology Journal 19, 2300327 (2024). doi: 10.1002/biot.202300327
[2] https://www.addgene.org/69496/
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 226
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]